Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€100.60
08.11.22
€150.00
31.01.25
5.77%
05.05.23

Could be worthwhile Investment >10% per year
BiotechBee 
08.11.22 70%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€100.60
08.11.22
€150.00
31.01.25
5.77%
05.05.23

Could be worthwhile Investment >10% per year
BiotechBee 
08.11.22 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
gerihouse 
04.11.22 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.62
03.11.22
-
03.11.23
13.26%
10.11.22

Could be very worthwhile Investment >20% year
Wolf_of_WS 
03.11.22 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
01.11.22 70%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
01.11.22 70%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
01.11.22 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
29.10.22 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
-
29.10.23
40.63%
30.10.23

Could be worthwhile Investment >10% per year
melinda 
29.10.22 20%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
michaelkr 
28.10.22 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
michaelkr 
28.10.22 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
michaelkr 
28.10.22 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
michaelkr 
28.10.22 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
michaelkr 
28.10.22 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
michaelkr 
28.10.22 50%
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
Wolf_of_WS 
28.10.22 50%
buy
Rocket Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€17.96
26.10.22
€28.00
31.12.24
15.29%
08.06.24

Could be very worthwhile Investment >20% year
BiotechBee 
26.10.22 70%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.67
26.10.22
€35.00
31.12.24
-41.33%
21.12.22

Could be very worthwhile Investment >20% year
BiotechBee 
26.10.22 70%
sell
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€218.90
25.10.22
€190.00
25.10.23
11.47%
26.10.23

Could be worthwhile Investment >10% per year
melinda 
25.10.22 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.78
25.10.22
€5.00
31.12.24
-23.55%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
25.10.22 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€4.50
24.10.23
-3.11%
25.10.23

Could be worthwhile Investment >10% per year
melinda 
24.10.22 20%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€7.00
24.10.23
18.42%
29.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
24.10.22 60%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€44.90
18.10.22
-
18.11.26
-44.54%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€44.90
18.10.22
-
18.11.26
-44.54%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
sell
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
18.10.22
-
18.10.23
0.78%
29.10.22

Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
me8 
18.10.22 0%